As shown in Fig. 4h, i, targeting NCAPG2 could significantly inhibit the size and weights of orthotopic tumor (Student’s t-test P < 0.05), while there was no significant difference in body weight between the experimental and control group (Fig. 4j). Here, NCAPG2 is linked to neoplasm.